Peptides
MOTS-C
- Research classification
- Peptides
For laboratory research use only. Not for human or veterinary use.
Lot & quality
Lot-specific analytical documentation
No verified lot documentation is published for this compound yet. Results, laboratories and purity values are never shown without a source record for the exact lot.
View available lot-specific analytical documentationEnter lot number
Verification connects to the BioNex lot and COA records in a later phase — no results are returned yet
- 01
Lot Number
- 02
COA
- 03
HPLC
- 04
Mass Spectrometry
- 05
Purity
- 06
Laboratory
- 07
Testing Date
- 08
QR Verification
Research snapshot
Verified research records currently indexed by BioNex
- Publication records
- 101
- Registered clinical trials
- 5
- Human interventional
- 1
- Human observational
- 2
- Preclinical
- 8
- Reviews
- 7
- Years indexed
- 2015–2026
Categories are listed separately and must not be added together: publication records and registered trial records are different record types, and a single study may appear in more than one category.
Compound profile
Research overview
Curated research content has not yet been imported for this compound. No generated summary is shown in its place.
Classification
Research areas
- Mitochondrial Research
- Metabolic Signaling
Targets
Mechanisms under investigation
AMPK-associated metabolic regulation (preclinical)
Preclinical observation
In the original characterisation, MOTS-c was reported to act via the folate/AICAR-AMPK axis in cell and rodent models. Evidence is preclinical; human confirmation is not established.
Source
Evidence
Evidence breakdown
Direct compound evidence
100
Publication records indexed as describing this compound directly.
Related evidence
0
Parent-molecule or fragment literature. Counted separately and never added to direct evidence.
Human research
- Human interventional1
- Human observational2
Records describing research in human participants.
Preclinical research
- Animal8
Animal and laboratory records. Not human evidence.
Review literature
- Reviews7
Reviews summarise other work rather than reporting new results.
Registered clinical trials
- Registered trial records5
Registration records a study, not a result. Trials are counted separately from publications.
Scientific identity
Compound identity
- Canonical scientific name
- MOTS-c (mitochondrial open reading frame of the 12S rRNA type-c peptide)
- Molecular formula
- C101H152N28O22S2
- Molecular weight
- 2174.6 g/mol
- CAS number
- 1627580-64-6
- Sequence
- MRWQEMGYIFYPRKLR
- Sequence length
- 16 residues
- PubChem CID
- 146675088
- UNII
- A5CV6JFB78
- Research classification
- Peptides
Indexed literature describes: Identity data describe the parent 16-residue MOTS-c peptide as represented by PubChem CID 146675088 (free peptide, not an acetate or TFA salt record).
These records describe the scientific entity reported in the literature. Lot-specific analytical documentation is available through BioNex Quality Verification when provided for the applicable lot.
Scientific data
- Compound
- MOTS-C
- Molecular formula
- C101H152N28O22S2
- Molecular weight
- 2174.6 g/mol
- CAS number
- 1627580-64-6
- Peptide sequence
- MRWQEMGYIFYPRKLR
- Research classification
- Peptides
Global research
Research records by jurisdiction
Jurisdictions appear only where an indexed record establishes them. Research recorded in one country never implies authorisation in another.
Loading Greece records
Published research
Representative recent records
Verified records currently indexed by BioNex
Loading records
Scientific identity records describe the entity reported in the literature. Lot-specific analytical documentation is available through BioNex Quality Verification when provided for the applicable lot.
BioNex Research Intelligence summarizes and organizes scientific literature for research and educational purposes. Inclusion of a publication, clinical trial, or regulatory record does not constitute endorsement, clinical guidance, or evidence of safety or efficacy for human use.
Related
